Skip to main content

Quantum Biopharma Ltd 6-K, filed Nov 13, 2026

Quantum Biopharma Ltd. (QNTM)

6-K 2026-11-13 For: 2026-11-13
View Original
Added on November 13, 2026

About this 6-K

Quantum Biopharma Ltd filed this 6-K on November 13, 2026.

Quantum BioPharma Ltd. reported 91% shareholder equity growth to US$9.77 million and US$12.22 million in combined cash and digital assets as of September 30, 2026. It also signed a study start-up agreement with Thermo Fisher Scientific for its Lucid-MS Phase 2 trial. AI summary